The findings of this study demonstrate that CA125 and HE4 may be utilised as markers in future prediction models integrating information on serum tumour marker levels with the results of accessible and cost-effective imaging methods capable of describing the extent of uterine infiltration. The gene discussed is MUC16; the disease is neoplasm.